[A study of combined chemotherapy with MMC, ADM, CDDP, etoposide (VP-16), 5'DFUR (MAC-VD therapy) in advanced cancer and local relapse of the stomach].

K Yasutake(Shiga Medical Center for Adults), Takahiro Masuda(Jichi Medical University), Kazuyuki Matsushita, M Tokisue, S Ohno, Yuichi Yoshimura, Mototsugu Oya(Keio University), Yoshinori Imamura(Kobe University)

PubMed

March 1, 1990

Cited by 1

Related Papers

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

|Oncology Reports|2015|852

SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

|American Journal of Physiology-Renal Physiology|2013|481

Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

|American Journal of Physiology-Renal Physiology|2013|308

Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice

|American Journal of Physiology-Renal Physiology|2012|158

Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume

|Physiological Reports|2020|135